Where can I buy the genuine drug Cosibelimab in China?
As of now, cosibelimab (Cosibelimab) has not been approved by the National Medical Products Administration (NMPA) in China, so the drug cannot be purchased through formal channels in domestic hospitals and pharmacies. This means that if patients need to use this drug for treatment, they are temporarily unable to obtain it from pharmacies or tertiary hospitals in China, and it is not included in the Chinese Medical Insurance Drug List.
Currently, if domestic patients do have treatment needs, there are two main ways to obtain genuine Cosibelimab: one is by participating in ongoing international multi-center clinical trials; the other is through overseas medical channels, using third-party formal cross-border medical platforms or drug direct mail services provided by overseas hospitals to purchase original drugs. This type of channel is usually managed by compliant pharmaceutical service agencies and has a certain degree of formality and traceability, but the price is high.

It is important to note that there are some"personal purchasers" or unauthorized online platforms selling so-called "genuine" Cosibelimab on the market. These sources carry great risks, including problems such as unknown sources of drugs, irregular storage and transportation, and difficulty in distinguishing authenticity. If patients purchase drugs through informal channels without authorization, they may face serious consequences such as medication failure or insufficient monitoring of side effects.
In the future, asCosibelimab is gradually used in the European and American markets and treatment data continues to accumulate, it is expected to submit a marketing application to the Chinese drug regulatory agency. Once approved by NMPA, patients will be able to obtain stable and controllable medication channels within the domestic formal medical system. Therefore, it is recommended that patients who intend to use this drug fully communicate with professional oncologists or pharmaceutical consultants and choose safe, legal, and professional ways to obtain the drug.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)